InMed Pharmaceuticals Statistics
Total Valuation
INM has a market cap or net worth of $3.43 million. The enterprise value is -$539,981.
Important Dates
The last earnings date was Monday, May 12, 2025, after market close.
| Earnings Date | May 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
INM has 1.21 million shares outstanding. The number of shares has increased by 138.87% in one year.
| Current Share Class | 1.21M |
| Shares Outstanding | 1.21M |
| Shares Change (YoY) | +138.87% |
| Shares Change (QoQ) | +55.12% |
| Owned by Insiders (%) | 0.61% |
| Owned by Institutions (%) | 6.41% |
| Float | 1.12M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.41 |
| Forward PS | n/a |
| PB Ratio | 0.47 |
| P/TBV Ratio | 0.62 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.49, with a Debt / Equity ratio of 0.12.
| Current Ratio | 3.49 |
| Quick Ratio | 2.77 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -23.00 |
Financial Efficiency
Return on equity (ROE) is -91.71% and return on invested capital (ROIC) is -50.42%.
| Return on Equity (ROE) | -91.71% |
| Return on Assets (ROA) | -44.64% |
| Return on Invested Capital (ROIC) | -50.42% |
| Return on Capital Employed (ROCE) | -108.65% |
| Revenue Per Employee | $378,538 |
| Profits Per Employee | -$639,346 |
| Employee Count | 13 |
| Asset Turnover | 0.43 |
| Inventory Turnover | 3.31 |
Taxes
In the past 12 months, INM has paid $7,100 in taxes.
| Income Tax | 7,100 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -59.76% in the last 52 weeks. The beta is 0.47, so INM's price volatility has been lower than the market average.
| Beta (5Y) | 0.47 |
| 52-Week Price Change | -59.76% |
| 50-Day Moving Average | 2.68 |
| 200-Day Moving Average | 4.06 |
| Relative Strength Index (RSI) | 49.41 |
| Average Volume (20 Days) | 210,039 |
Short Selling Information
The latest short interest is 31,503, so 2.61% of the outstanding shares have been sold short.
| Short Interest | 31,503 |
| Short Previous Month | 43,541 |
| Short % of Shares Out | 2.61% |
| Short % of Float | 2.81% |
| Short Ratio (days to cover) | 0.62 |
Income Statement
In the last 12 months, INM had revenue of $4.92 million and -$8.31 million in losses. Loss per share was -$11.50.
| Revenue | 4.92M |
| Gross Profit | 1.60M |
| Operating Income | -8.08M |
| Pretax Income | -6.07M |
| Net Income | -8.31M |
| EBITDA | -7.87M |
| EBIT | -8.08M |
| Loss Per Share | -$11.50 |
Full Income StatementBalance Sheet
The company has $4.72 million in cash and $848,594 in debt, giving a net cash position of $3.87 million or $3.21 per share.
| Cash & Cash Equivalents | 4.72M |
| Total Debt | 848,594 |
| Net Cash | 3.87M |
| Net Cash Per Share | $3.21 |
| Equity (Book Value) | 7.02M |
| Book Value Per Share | 5.82 |
| Working Capital | 4.57M |
Full Balance SheetCash Flow
| Operating Cash Flow | -7.02M |
| Capital Expenditures | n/a |
| Free Cash Flow | -7.02M |
| FCF Per Share | -$5.81 |
Full Cash Flow StatementMargins
Gross margin is 32.43%, with operating and profit margins of -164.29% and -168.90%.
| Gross Margin | 32.43% |
| Operating Margin | -164.29% |
| Pretax Margin | -168.75% |
| Profit Margin | -168.90% |
| EBITDA Margin | -159.93% |
| EBIT Margin | -164.29% |
| FCF Margin | n/a |